These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

765 related items for PubMed ID: 26696647

  • 1. Prediction of Early Arterial Recanalization and Tissue Fate in the Selection of Patients With the Greatest Potential to Benefit From Intravenous Tissue-Type Plasminogen Activator.
    Leiva-Salinas C, Patrie JT, Xin W, Michel P, Jovin T, Wintermark M.
    Stroke; 2016 Feb; 47(2):397-403. PubMed ID: 26696647
    [Abstract] [Full Text] [Related]

  • 2. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M, Arihiro S, Miyashita F, Yamamoto H, Yamada N, Nagatsuka K, Minematsu K, Toyoda K.
    Cerebrovasc Dis; 2013 Feb; 36(4):299-305. PubMed ID: 24135558
    [Abstract] [Full Text] [Related]

  • 3. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I, Dembo T, Yoshimura S, Sakai N, Okada Y, Kitagawa K, Kimura K, Hyogo T, Yamagami H, Egashira Y, Tanahashi N.
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [Abstract] [Full Text] [Related]

  • 4. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.
    Turc G, Apoil M, Naggara O, Calvet D, Lamy C, Tataru AM, Méder JF, Mas JL, Baron JC, Oppenheim C, Touzé E.
    Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603
    [Abstract] [Full Text] [Related]

  • 5. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D, Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology.
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [Abstract] [Full Text] [Related]

  • 6. The association of blood pressure and collateral circulation in hyperacute ischemic stroke patients treated with intravenous thrombolysis.
    Rusanen H, Saarinen JT, Sillanpää N.
    Cerebrovasc Dis; 2015 Aug; 39(2):130-7. PubMed ID: 25660943
    [Abstract] [Full Text] [Related]

  • 7. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator.
    Molina CA, Alexandrov AV, Demchuk AM, Saqqur M, Uchino K, Alvarez-Sabín J, CLOTBUST Investigators.
    Stroke; 2004 Jan; 35(1):151-6. PubMed ID: 14671245
    [Abstract] [Full Text] [Related]

  • 8. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
    Saqqur M, Shuaib A, Alexandrov AV, Sebastian J, Khan K, Uchino K.
    Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
    [Abstract] [Full Text] [Related]

  • 9. Every 15-min delay in recanalization by intra-arterial therapy in acute ischemic stroke increases risk of poor outcome.
    He AH, Churilov L, Mitchell PJ, Dowling RJ, Yan B.
    Int J Stroke; 2015 Oct; 10(7):1062-7. PubMed ID: 25918863
    [Abstract] [Full Text] [Related]

  • 10. Influence of arterial occlusion on outcome after intravenous thrombolysis for acute ischemic stroke.
    Medlin F, Amiguet M, Vanacker P, Michel P.
    Stroke; 2015 Jan; 46(1):126-31. PubMed ID: 25424477
    [Abstract] [Full Text] [Related]

  • 11. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
    Coutts SB, Dubuc V, Mandzia J, Kenney C, Demchuk AM, Smith EE, Subramaniam S, Goyal M, Patil S, Menon BK, Barber PA, Dowlatshahi D, Field T, Asdaghi N, Camden MC, Hill MD, TEMPO-1 Investigators.
    Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
    [Abstract] [Full Text] [Related]

  • 12. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
    Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, Albers GW, Cognard C, Cohen DJ, Hacke W, Jansen O, Jovin TG, Mattle HP, Nogueira RG, Siddiqui AH, Yavagal DR, Devlin TG, Lopes DK, Reddy V, du Mesnil de Rochemont R, Jahan R, SWIFT PRIME Investigators.
    Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
    [Abstract] [Full Text] [Related]

  • 13. Prediction of recanalization trumps prediction of tissue fate: the penumbra: a dual-edged sword.
    Zhu G, Michel P, Aghaebrahim A, Patrie JT, Xin W, Eskandari A, Zhang W, Wintermark M.
    Stroke; 2013 Apr; 44(4):1014-9. PubMed ID: 23463751
    [Abstract] [Full Text] [Related]

  • 14. Does Diffusion Lesion Volume Above 70 mL Preclude Favorable Outcome Despite Post-Thrombolysis Recanalization?
    Tisserand M, Turc G, Charron S, Legrand L, Edjlali M, Seners P, Roca P, Lion S, Naggara O, Mas JL, Méder JF, Baron JC, Oppenheim C.
    Stroke; 2016 Apr; 47(4):1005-11. PubMed ID: 26979862
    [Abstract] [Full Text] [Related]

  • 15. Importance of cerebral artery recanalization in patients with stroke with and without neurological improvement after intravenous thrombolysis.
    Kharitonova TV, Melo TP, Andersen G, Egido JA, Castillo J, Wahlgren N, SITS investigators.
    Stroke; 2013 Sep; 44(9):2513-8. PubMed ID: 23881960
    [Abstract] [Full Text] [Related]

  • 16. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L, Nighoghossian N, Hermier M, Adeleine P, Berthezène Y, Philippeau F, Honnorat J, Froment JC, Trouillas P.
    J Neurol Sci; 2004 Oct 15; 225(1-2):3-9. PubMed ID: 15465079
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity of diffusion- and perfusion-weighted imaging for diagnosing acute ischemic stroke is 97.5%.
    Simonsen CZ, Madsen MH, Schmitz ML, Mikkelsen IK, Fisher M, Andersen G.
    Stroke; 2015 Jan 15; 46(1):98-101. PubMed ID: 25388415
    [Abstract] [Full Text] [Related]

  • 18. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action.
    Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P, Watson T, Goyal M, Demchuk AM.
    Stroke; 2010 Oct 15; 41(10):2254-8. PubMed ID: 20829513
    [Abstract] [Full Text] [Related]

  • 19. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
    Labiche LA, Al-Senani F, Wojner AW, Grotta JC, Malkoff M, Alexandrov AV.
    Stroke; 2003 Mar 15; 34(3):695-8. PubMed ID: 12624293
    [Abstract] [Full Text] [Related]

  • 20. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW, Kim KJ, Noh WY, Jang MS, Yang MH, Han MK, Kwon OK, Jung C, Kim JH, Oh CW, Lee JS, Lee J, Bae HJ.
    Cerebrovasc Dis; 2013 Mar 15; 35(5):461-8. PubMed ID: 23735898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.